EDAP Announces Final U.S. 2021 Reimbursement Rules for High Intensity Focused Ultrasound (HIFU)
December 09, 2020 08:00 ET
|
EDAP TMS S.A.
Final rules establish, for the first time, a Category 1 CPT code and reimbursement to physicians performing ablation of malignant prostate tissue with HIFU in the USPhysician reimbursement for...
EDAP Reports Third Quarter 2020 Results and Provides Operational Update
November 18, 2020 16:35 ET
|
EDAP TMS S.A.
Generated strongest total revenue quarter of 2020 Reported growth in HIFU procedure revenues year-over-year notwithstanding ongoing COVID-19 pandemicCompleted sales to renowned healthcare...
EDAP Announces Exclusive Distribution Agreement with Leading Italian Medical Device Distributor AB Medica
November 17, 2020 08:00 ET
|
EDAP TMS S.A.
Partnership further extends the availability of EDAP’s High Intensity Focused Ultrasound (HIFU) technology to one of the largest markets in Europe Complementary to AB Medica’s extensive product...
EDAP Announces Presentation at the Jefferies Virtual London Healthcare Conference
November 10, 2020 08:46 ET
|
EDAP TMS S.A.
LYON, France, November 10, 2020 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that management will be presenting at the Jefferies Virtual London...
EDAP TMS SA to Announce Third Quarter 2020 Financial Results on November 18, 2020
November 09, 2020 08:50 ET
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, November 19 at 8:30 am EDT LYON, France, November 9, 2020 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today...
EDAP Hosting Key Opinion Leader Call on Focal One® and ExactVu™
September 15, 2020 08:00 ET
|
EDAP TMS S.A.
Call to be Held Tuesday, September 22nd @ 8am Eastern Time LYON, France, September 15, 2020 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that it...
EDAP Announces Presentation at the HC Wainwright Virtual 22nd Annual Global Investment Conference
September 09, 2020 08:00 ET
|
EDAP TMS S.A.
LYON, France, September 9, 2020 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that management will be presenting at the HC Wainwright Virtual 22nd...
EDAP Announces First Patients Treated in Phase 2 Study of Focal One for the Treatment of Deep Invasive Endometriosis
September 03, 2020 08:00 ET
|
EDAP TMS S.A.
· First patients already treated as recruitment accelerates LYON, France, September 3, 2020 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today...
EDAP Reports Second Quarter 2020 Results and Provides Operational Update
August 26, 2020 16:35 ET
|
EDAP TMS S.A.
Completed multiple Focal One sales to renowned U.S. and international health care institutions, including multiple Focal One™-ExactVu™ bundled salesAnnounced first two U.S. publications in Journal of...
EDAP Announces Approval for Phase II Study Evaluating High Intensity Focused Ultrasound (HIFU) for Deep Invasive Endometriosis
August 25, 2020 08:00 ET
|
EDAP TMS S.A.
Multicenter study to commence in September in FranceReinforces company’s recent shift in strategic focus toward development of additional high-value HIFU tissue ablation indications LYON, France,...